CA
RXST icon

Cliff Asness’s RxSight RXST Stock Holding History

Cliff Asness’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.39M Buy
1,533,826
+897,697
+141% +$5.42M ﹤0.01% 1756
2026
Q1 		$3.92M Buy
636,129
+537,009
+542% +$4.46M ﹤0.01% 1909
2025
Q4 		$1.03M Buy
99,120
+73,083
+281% +$733K ﹤0.01% 2535
2025
Q3 		$234K Sell
26,037
-38,263
-60% -$336K ﹤0.01% 3190
2025
Q2 		$836K Buy
64,300
+25,993
+68% +$391K ﹤0.01% 2306
2025
Q1 		$967K Sell
38,307
-11,844
-24% -$352K ﹤0.01% 2032
2024
Q4 		$1.72M Sell
50,151
-11,045
-18% -$498K ﹤0.01% 1610
2024
Q3 		$3.02M Buy
61,196
+2,562
+4% +$131K ﹤0.01% 1291
2024
Q2 		$3.53M Buy
58,634
+18,688
+47% +$1.07M 0.01% 1193
2024
Q1 		$2.06M Buy
39,946
+28,683
+255% +$1.41M ﹤0.01% 1398
2023
Q4 		$454K Buy
11,263
+3,257
+41% +$95.5K ﹤0.01% 1923
2023
Q3 		$223K Buy
+8,006
New +$239K ﹤0.01% 2106

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Cliff Asness's RXST Position: Q2 2026 in Review

Cliff Asness increased its RxSight (RXST) stake by 141% in Q2 2026, buying an estimated $5.42M and bringing the position to 1,533,826 shares worth $7.39M. The position accounts for ﹤0.01% of the portfolio, ranked #1756.

Cliff Asness first reported a position in RXST in Q3 2023 and has held it in 12 quarters since. 150 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Cliff Asness held 1,533,826 shares of RxSight worth $7.39M as of Q2 2026.
  • Cliff Asness bought 897,697 RxSight shares in Q2 2026, an estimated $5.42M.
  • RxSight made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #1756 holding.
  • Cliff Asness first reported a position in RxSight in Q3 2023 and has held it in 12 quarters since.
  • 150 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.